These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 15713105)

  • 21. Quantitative analysis of amyloid-beta peptides in cerebrospinal fluid using immunoprecipitation and MALDI-Tof mass spectrometry.
    Gelfanova V; Higgs RE; Dean RA; Holtzman DM; Farlow MR; Siemers ER; Boodhoo A; Qian YW; He X; Jin Z; Fisher DL; Cox KL; Hale JE
    Brief Funct Genomic Proteomic; 2007 Jun; 6(2):149-58. PubMed ID: 17584762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of delayed CSF storage on concentrations of phospho-tau protein (181), total tau protein and beta-amyloid (1-42).
    Kaiser E; Schönknecht P; Thomann PA; Hunt A; Schröder J
    Neurosci Lett; 2007 May; 417(2):193-5. PubMed ID: 17408854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alzheimer's biomarker initiative hits its stride.
    Miller G
    Science; 2009 Oct; 326(5951):386-9. PubMed ID: 19833956
    [No Abstract]   [Full Text] [Related]  

  • 24. Liquid chromatography/tandem mass spectrometry characterization of oxidized amyloid beta peptides as potential biomarkers of Alzheimer's disease.
    Inoue K; Garner C; Ackermann BL; Oe T; Blair IA
    Rapid Commun Mass Spectrom; 2006; 20(5):911-8. PubMed ID: 16470704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on amyloid-beta homeostasis markers for sporadic Alzheimer's disease.
    Zetterberg H
    Scand J Clin Lab Invest; 2009; 69(1):18-21. PubMed ID: 19199126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous determination of biomarkers for Alzheimer's disease using sol-gel-derived optical array biosensor.
    Doong RA; Lee PS; Anitha K
    Biosens Bioelectron; 2010 Jul; 25(11):2464-9. PubMed ID: 20444591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amyloid imaging in Alzheimer's disease.
    Nordberg A
    Neuropsychologia; 2008; 46(6):1636-41. PubMed ID: 18468648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
    Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
    Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imaging and in vivo quantitation of beta-amyloid: an exemplary biomarker for Alzheimer's disease?
    Nichols L; Pike VW; Cai L; Innis RB
    Biol Psychiatry; 2006 May; 59(10):940-7. PubMed ID: 16487944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease.
    Barghorn S; Nimmrich V; Striebinger A; Krantz C; Keller P; Janson B; Bahr M; Schmidt M; Bitner RS; Harlan J; Barlow E; Ebert U; Hillen H
    J Neurochem; 2005 Nov; 95(3):834-47. PubMed ID: 16135089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
    Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatment.
    Blennow K
    Expert Rev Mol Diagn; 2005 Sep; 5(5):661-72. PubMed ID: 16149870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropsychiatric correlates of cerebrospinal fluid biomarkers in Alzheimer's disease.
    Skogseth R; Mulugeta E; Jones E; Ballard C; Rongve A; Nore S; Alves G; Aarsland D
    Dement Geriatr Cogn Disord; 2008; 25(6):559-63. PubMed ID: 18536520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrillar and oligomeric beta-amyloid as distinct local biomarkers for Alzheimer's disease.
    Montalto MC; Farrar G; Hehir CT
    Ann N Y Acad Sci; 2007 Feb; 1097():239-58. PubMed ID: 17413026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a specific ELISA for the quantitative study of amino-terminally truncated beta-amyloid peptides.
    El Mouedden M; Vandermeeren M; Meert T; Mercken M
    J Neurosci Methods; 2005 Jun; 145(1-2):97-105. PubMed ID: 15922029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterisation of two antibodies to oligomeric Abeta and their use in ELISAs on human brain tissue homogenates.
    van Helmond Z; Heesom K; Love S
    J Neurosci Methods; 2009 Jan; 176(2):206-12. PubMed ID: 18824027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific recognition of the C-terminal end of A beta 42 by a high affinity monoclonal antibody.
    Axelsen TV; Holm A; Birkelund S; Christiansen G; Ploug M; Holm IE
    Mol Immunol; 2009 Jul; 46(11-12):2267-73. PubMed ID: 19447496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice.
    Muhs A; Hickman DT; Pihlgren M; Chuard N; Giriens V; Meerschman C; van der Auwera I; van Leuven F; Sugawara M; Weingertner MC; Bechinger B; Greferath R; Kolonko N; Nagel-Steger L; Riesner D; Brady RO; Pfeifer A; Nicolau C
    Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9810-5. PubMed ID: 17517595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain.
    Boche D; Zotova E; Weller RO; Love S; Neal JW; Pickering RM; Wilkinson D; Holmes C; Nicoll JA
    Brain; 2008 Dec; 131(Pt 12):3299-310. PubMed ID: 18953056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease.
    Schoonenboom NS; van der Flier WM; Blankenstein MA; Bouwman FH; Van Kamp GJ; Barkhof F; Scheltens P
    Neurobiol Aging; 2008 May; 29(5):669-75. PubMed ID: 17208336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.